A new antimicrobial peptide, herein named Stigmurin, was selected based on a transcriptomic analysis of the Brazilian yellow scorpion Tityus stigmurus venom gland, an underexplored source for toxic peptides with possible biotechnological applications. Stigmurin was investigated in silico, by circular dichroism (CD) spectroscopy, and in vitro. The CD spectra suggested that this peptide interacts with membranes, changing its conformation in the presence of an amphipathic environment, with predominance of random coil and beta-sheet structures. Stigmurin exhibited antibacterial and antifungal activity, with minimal inhibitory concentrations ranging from 8.7 to 69.5 M. It was also showed that Stigmurin is toxic against SiHa and Vero E6 cell lines. The results suggest that Stigmurin can be considered a potential anti-infective drug.
Introduction
Antimicrobial peptides (AMPs) are important components of the innate immune system, showing a broad spectrum of action against microbes [33, 40] . It is believed that the mechanism of action of these peptides is not dependent on interaction with a specific receptor, making them interesting therapeutic alternatives when compared to available antibiotics; the latter act mainly by inhibiting biosynthetic pathways and are more prone to induce microbial Scorpiops tibetanus [10] , TsAP-1 and TsAP-2 both from Tityus serrulatus [31] . A recent comprehensive review on the different classes of AMP found in the venom of several scorpion species can be found elsewhere [35] . Taken together, these examples indicate that scorpion venoms are rich resources for the study of antimicrobial peptides.
The members of Buthidae scorpions are dangerous to humans; to date, approximately 500 species have been identified, of which 25 can cause lethal accidents [60] . These animals have a wide distribution around the globe: species of the genera Androctonus, Leiurus and Buthus are found in North Africa, Middle East and India, genus Parabuthus is found in South Africa and genus Tityus in South America, especially Brazil [73] . In Brazil, studies on the chemical properties of scorpion venoms have been performed more frequently in T. serrulatus, T. bahiensis and T. fasciolatus [5, 39] . In contrast, the venom of Tityus stigmurus was not yet explored as an arsenal of toxins with potential biotechnological applications. Our group has previously reported the identification of a transcript encoding an antimicrobial peptide (AMP) from T. stigmurus, which was the most abundant transcript in the venom gland [3] . In the present study, this peptide (herein named Stigmurin) had its structure evaluated in silico and by circular dichroism, and its biological activities investigated against different microorganisms and in different mammal cell lines in vitro.
Materials and methods

Bioinformatic and phylogenetic analyses
The complete nucleotide sequence TSTI0001C selected from the full length cDNA library [3] was analyzed by ORF-Finder [70] . Multiple alignments were performed with CLUSTAL X [44] . Putative signal peptide, propeptide and mature peptide were predicted using SignalP v4.0 [57] and ProP 1.0 [24] . The amino acid sequence was subjected to a similarity search in the database of the National Center for Biotechnology Information (NCBI) using BLASTp [4] .
The phylogenetic analysis was performed using AMP sequences with known three-dimensional structure, obtained from the Antimicrobial Peptide Database (APD; http://aps.unmc.edu/AP/main.php) [78] . Selected sequences were aligned using the programs MAFFT [41] and MUSCLE [25] . A best-fit adjustment of the amino acids substitution model was performed using the ProtTest tool [20] . The dendrogram was calculated based on a Bayesian analysis using the BEAST tool [23] . Inferences were conducted in two independent runs with four simultaneous chains each, and fixed WAG model, allowing gamma distributed rates among sites. Each Markov Chain was initiated with a random tree, ran for 10 6 generations, and sampled every 100 generations. Consensus tree was estimated following a discarded burn-in of 1,000,000 trees. The convergence of the simultaneous runs was assessed using the Tracer tool v.1.5 [22] , to evaluate the statistic support and robustness of the Bayesian analysis. Generated trees were edited in the software FigTree (http://tree.bio.ed.ac.uk/software/figtree/) [62] .
Peptide modeling
Stigmurin modeling was performed using I-TASSER [68] , and 5 models were generated. The structures were validated by checking Ramachandran plots, C␤ derivation, clash scores, rotamers, backbone bonds and backbone angles [12] . The models were analyzed and sorted by score values, and pdb files were visualized using USFC Chimera software [83] . The top three models were submitted to a molecular dynamics analysis.
Models refinement
Molecular dynamics simulations were performed to optimize the obtained models. All simulations were performed in explicit water (TIP3P) or 2,2,2-trifluoroethanol (TFE) 70%, using GROMACS [71] . Simulation package and AMBER 99SB-ILDN force field were used [45] . The protonation state of the protein residues at pH 7.0 was determined by PROPKA web server [53] . The simulation time step was 0.5 s; the minimum distance between any atom of the protein and the box wall was 1.2 nm. Coulomb and van der Waals interactions within a shorter-range cutoff of 1.0 nm were computed every time step. Particle Mesh Ewald was employed to minimize the effects of truncating the electrostatic interactions beyond the 1.2 nm long-range cutoff. Covalent bonds in the protein were constrained using the LINCS algorithm [37] .
Circular dichroism (CD)
Far-UV spectra of the peptide were recorded at 25 • C in water, TFE 20%, 50% or 70% (v/v) or sodium dodecyl sulfate (SDS), using 0.1 cm pathlength quartz cuvette in a Jasco J-810 spectropolarimeter (Jasco, Tokyo, Japan) with Peltier-type temperature controller. Each spectrum corresponds to an average of five scans taken from 182 to 260 nm, at a scan rate of 50 nm/min [77, 80] . Secondary structure of Stigmurin was determined by deconvoluting CD data using CONTIN/LL [72] , CDSSTR [14] and K2D [6] algorithms. We have also used CAPITO web-server [81] to verify the results.
Peptide synthesis
Mature peptide (without both, signal peptide and propeptide), herein named Stigmurin, was synthesized in its amidated form by Invitrogen Life Technologies, USA, using FMOC solid-phase technology [11, 49] . C-terminal amidation was selected based on the presence, in the complete translated sequence, of a highly conserved post-translational processing signal (Gly-Arg-Arg-Lys), of which the proteolytic cleavage typically precedes the amidation of the adjacent residue in the mature peptide, as described previously for several similar scorpion peptides [17, 31, 42, 86, 88] . The synthetic peptide was purified by reverse-phase HPLC (>90% purity) and its molecular weight was confirmed by mass spectrometry performed by the supplier (Supplementary Fig. 1 ).
Supplementary Fig. 1 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j. peptides.2015.03.003.
Microorganism strains and in vitro antimicrobial assay
For antimicrobial assays, the following strains were used: Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922), methicillin-resistant Staphylococcus aureus MRSA (ATCC 33591), Candida albicans (ATCC 90028), Candida krusei (ATCC 6258) and Candida glabrata (ATCC 90030).
Minimal inhibitory concentration (MIC) was determined by broth microdilution method in Mueller Hinton Broth (MHB), following the guidelines of the Clinical and Laboratory Standards Institute CLSI [13] , with small variations as indicated below. Inocules were prepared at 1 × 10 5 colony forming units per milliliter (CFU/mL) for bacteria and to 1 × 10 4 CFU/mL for yeasts. One hundred microliters of the bacterial suspension and 100 l of serially diluted Stigmurin were added to each well in microtiter plates, to a final peptide concentration of 1.1-139.5 M. The plates were incubated at 35 • C for 24 h (bacteria) or at 30 • C for 48 h (yeasts) with continuous shaking in a humidified atmosphere. Positive growth controls were inoculated as describe above, without addition of peptide. Sterile MHB was used as negative control. The MIC was defined as the lowest concentration able to prevent microbial growth, based on optical density (absorbance at 550 nm) [82] .
Hemolysis assay
Hemolytic activity was assessed by incubating a suspension of healthy human donor erythrocytes with increasing concentrations of synthetic peptide. Cells were first washed three times by centrifugation at 8000 × g for 5 min in 1X PBS, pH 7.4 [52, 58] , then incubated with Stigmurin (1.1-139.5 M) at 37 • C for 180 min. Optical density (absorbance at 540 nm) of supernatants was recorded using a plate reader (Epoch-Biotek, Winooski, VT, USA).
Cytotoxicity assay
The cytotoxicity of the synthetic peptide was evaluated in SiHa cells (human cervical cancer cell line) and Vero E6 cells (African green monkey kidney epithelial cell line). Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Sigma-Aldrich, Germany). Confluent cell-monolayers contained in 96-well plates were incubated with serially diluted Stigmurin (2.17-279 M) in RPMI-1640 for SiHa cells, or Leibovitz (L-15) for Vero E6 cells, at 37 • C for 24 h. Then, 50 L of MTT (1 mg/mL) was added to each well and further incubated for 4 h at 37 • C. Supernatants were removed and replaced by 100 L of dimethyl sulfoxide (DMSO) to solubilize formazan crystals [51] , and absorbance was measured at 540 nm. Peptide concentration necessary to reduce cell viability in 50% (IC 50 ) was calculated by comparison with untreated cells.
Statistical analysis
For the interpretation of bioassays, multiple-group comparisons were evaluated by analysis of variance (ANOVA) using Graph Pad Prism software (Version 5.00, Graph Pad, San Diego, CA, USA). Differences were considered significant when p < 0.05.
Results
Bioinformatic and phylogenetic analyses
From the cDNA library obtained from T. stigmurus venom glands [3], the clone TSTI0001C was isolated and identified, coding for a mature protein with 73 amino acid residues [GenBank: JK483709], named Stigmurin. The protein sequence shows a 22 amino acids-long signal peptide, and propeptide starting with the highly conserved post-translational processing signal: Gly-ArgArg-Lys-Arg (GRRKR), and 29 amino acids preceding the mature protein of 17 amino acids (Fig. 1) . Multiple sequence alignment with peptides retrieved from GenBank (Fig. 2) showed high similarity between Stigmurin and PAMs of different scorpion species, all exhibiting experimentally proved in vitro antimicrobial activity [2, 8, 17, 21, 31, 47, 88] . Several amino acid residues are observed in conserved positions of these peptides, especially in mature toxin region. Probably all aligned sequences undergo post-translational modification, given the presence of the signal peptide, propeptide and cleavage site [31] . Interestingly, the phylogenetic analysis (Fig. 3 ) demonstrated that Stigmurin, along with the scorpion peptides Mucroporin and Bmkb1, exhibited significant sequence similarity (as well as an evolutive proximity) to phylloseptins, a family of antimicrobial peptides from South/Central American Phyllomedusinae frog skin [43, 61] .
According to structural modeling, it was observed that Stigmurin shows alpha-helical conformation (Fig. 4A) . The stability of the secondary structure depends on the environment by which it is surrounded; this is supported by two simulation experiments where the peptide changed from alpha-helix structure to a betasheet conformation when in water, whereas it assumed a random coil structure when the simulation was performed in TFE 70% ( Fig. 4B and C, and Supplementary videos 1 and 2).
Supplementary Videos 1 and 2 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j. peptides.2015.03.003.
Secondary structure evaluated by CD spectroscopy
The CD analysis of synthetic Stigmurin in aqueous solution showed a typical spectrum of disordered structure. When 20% TFE was added to the system, the dichroic spectrum changed; in 50% TFE, the deviation of the spectra from zero-value of ellipticity became more prominent, and the results were similar in 70% TFE, as well as in SDS above critical micelle concentration (CMC), a membrane-mimetic environment (Fig. 5A) . The spectra were analyzed by deconvolution using four different approaches [6, 14, 72, 81] . Fig. 5B presents the proportion of the sequence assuming alpha-helical, beta-sheet or random coil secondary structure in the different environments, calculated as the mean of the values found by the four methods. The results show a general predominance of random coil and beta-sheet conformation.
Antimicrobial activity
Stigmurin was active against Gram-positive bacterial strains Staphylococcus aureus and Methicillin-resistant S. aureus MRSA, and the yeasts C. albicans, C. krusei, and C. glabrata, but it was ineffective against Gram-negative E. coli (Table 1) . Interestingly, Stigmurin was found to possess low hemolytic activity (22%) at the highest concentration tested (139.5 M), as shown in Fig. 6 .
In vitro cytotoxicity
Stigmurin showed toxicity against SiHa cells, leading to 36%, 69% and 92% of non-viable cells after exposition to the peptide Table 1 Minimum inhibitory concentrations (MIC) of synthetic Stigmurin peptide against standard bacterial strains. Values represent mean ± SD (n = 3). **p < 0.01 and ***p < 0.001 compared to positive control.
Strains MIC (M ± SD)
Gram-positive
Staphylococcus aureus (ATCC 29213) 8.68 ± 1.1*** Methicillin-resistant S. aureus MRSA (ATCC 33591) 17.37 ± 1.2***
Gram-negative Escherichia coli (ATCC 25922) >139
Yeasts Candida albicans (ATCC 90028) 34.75 ± 1.4*** C. krusei (ATCC 6258) 69.5 ± 4.02** C. glabrata (ATCC 90030) 69.5 ± 2.83*** at concentrations of 69.8 M, 139.5 M and 279 M, respectively (Fig. 7A ). Cytotoxic effect it was also observed in Vero E6 cells, where 57% and 89% of the cells were non-viable after incubation with Stigmurin at concentrations of 139.5 M and 279 M, respectively (Fig. 7B) . The IC 50 parameter verifies that viability reduction was more prominent on human carcinoma lineage SiHa (IC 50 118 M), than on monkey epithelial cells Vero E6 (IC 50 150 M).
Discussion
The identification and analysis of Stigmurin demonstrated that this peptide has high sequence similarity to other non-disulfidebridged antimicrobial peptides [2, 8, 17, 21, 31, 47, 88] . Through multiple sequence alignment and phylogenetic analysis, it could be noticed a significant conservation of key amino acid residues that • C for 180 min. The activity was determined by measuring the absorbance at 540 nm, using PBS and distilled water as negative and positive lysis control, respectively. Percentage hemolysis was calculated relative to the positive control (100%). Values represent mean ± SD (n = 3). **p < 0.01 compared to positive control.
are characteristic of antimicrobial peptides [73] . This observation is consistent with the hypothesis that many AMPs are evolutionarily related within the Scorpionidae taxon, having arisen from multiple duplications of an ancestral gene [73, 86] . The diversification of AMPs could then be part of an evolutionary strategy driven by the rapid evolution of pathogens [67] . Furthermore, bioinformatic analysis showed evidence that Stigmurin is a new AMP.
Structural analysis of Stigmurin by molecular dynamics and CD showed that its structure differs when in the presence of water, SDS or TFE. These results suggest that it may assume different conformations depending on the environment, which is a common behavior in AMPs [74] . It is essential to highlight that, according to CD analysis, Stigmurin exhibited a more regular secondary structure when in contact with TFE or SDS. TFE diminishes the peptide interaction with the solvent and favors intramolecular interactions, thus increasing the chance of secondary structure conformation (in this work, mainly ␤-sheet) [65] . Stigmurin presented a different structure in the presence of water, mostly random coil. Furthermore, the contact with a micellar solution led to a conformational shift in Stigmurin's structure, indicating that it may interact with micelles, which mimic membranes [74] . This suggests that the mechanism of action of Stigmurin is through interaction with membranes, which is very common among other AMPs already characterized [33, 40, 65, 74, 85] .
It is noticed a discrepancy between the homology models (all alpha-helical structure, Fig. 4A ) with the findings from dynamics Fig. 7 . Citotoxicity of Stigmurin. Dose-response curves of cell viability as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay in cell lines SiHa (A) and Vero E6 (B). Cells were cultured in 96-well microtiter plates using RPMI-1640 or L-15 media in the presence of serially diluted Stigmurin (2.17-279 M) for 24 h. The activity was determined by measuring the absorbance at 540 nm after addition of MTT for 4 h and subsequent solubilization with DMSO. Values represent mean ± SD (n = 3). Statistical significance was analyzed using a paired t-test. *p < 0.05, **p < 0.01 and ***p < 0.001 compared to positive control. simulation ( Fig. 4B and C) and experimental CD results (Fig. 5A and  B) . Altogether, the present study revealed that Stigmurin alters its secondary structure according to the medium, which shows that the residues can be structured or flexible in specific conditions, possibly having a functional significance [33, 34, 74] . Another point to be discussed is that the molecular dynamics simulation agrees with deconvoluted CD results regarding the type of predominant structures, but not the tendency of variation in different media. This could derive from the deconvolution algorithms, which are optimized for larger proteins rather than for small peptides [6, 14, 72] , or from issues to accurately represent the dielectric properties with the force field employed in the simulations [38] . Nevertheless, it can be concluded that Stigmurin has an environment-dependent conformation.
In this work we have demonstrated that Stigmurin, a novel antimicrobial peptide, possesses antimicrobial activity against Gram-positive bacteria, including antibiotic-resistant pathogens (MRSA), and fungi. Peptide TsAP-1 from T. serrulatus venom, a highly similar scorpion AMP (96% identity) from a closely related species, presented poor antimicrobial activity (MIC > 120 M for S. aureus, E. coli and C. albicans) when compared to Stigmurin [31] . Both peptides have the same net charge (+2 considering the Cterminal amidation), and there are only two residues which differ in the mature peptide sequences, exchanging Phe24 and Leu34 in Stigmurin for a Leu and a Ser, respectively, in TsAP-1 [31] . It is possible that the different activity is a result of a decreased hydrophobicity conferred by Ser to TsAP-1. Peptide hydrophobicity, together with a positive net charge in an amphipathic arrangement, is considered a major requirement for their antimicrobial activity [59] . In contrast, despite a lower sequence similarity to Stigmurin (78%), peptide TsAP-2 from T. serrulatus has identical proportion of hydrophobic residues (10 out of 17) and presented a more similar activity, causing deleterious effects in Gram-positive bacterium S. aureus development, and in C. albicans, but being less effective against Gram-negative E. coli [31] .
In fact, activity against Gram-positive bacteria with a weaker activity against Gram-negative bacteria was also described for other non-disulfide-bridged peptides from scorpions such as Pandinin1 and -2, IsCT and IsCT2 [15, 18, 19] . Among these peptides, IsCT, IsCT2 and TsAP-2 present a conserved consensus sequence (X( 0-5 )IX 3 IX 3 IX 4 ) where the three Ile residues seem to play an important functional role [86] . This consensus is partially present in Stigmurin and Pandinin2, where the second Ile residue is substituted by other hydrophobic residues (Val and Phe, respectively). Here again, hydrophobicity seems to be a key aspect in the antimicrobial activity of cationic peptides. The initial electrostatic interaction with negatively charged surface molecules (e.g. teichoic acids in the Gram-positive cell wall), and subsequent membrane insertion are important steps in the process of killing; however, the mechanisms of action and the specific cellular targets can vary among peptides and among organisms for a given peptide [28] . Furthermore, it is important to note that the differences in the cell surface, or even differences in the absorption of the agent by each type of microorganism are other factors that can influence the MIC values [69] .
Infections by multi-drug resistant pathogens such as MRSA are reaching alarming numbers worldwide, frequently causing the death of hospital patients [55] . It is appreciated that the mechanism of action of AMPs, in contrast to most conventional antibiotics, is less prone to induce microbial resistance, and peptide antibiotics have been considered valuable alternatives in the treatment of such infections [55] . Our results suggest that Stigmurin can be a candidate molecule for use in antimicrobial therapy. Furthermore, at the concentration which Stigmurin has prominent antimicrobial activity, its hemolytic activity is only mild, supporting the potential use of this molecule for therapeutic purposes [88] . Interestingly, Stigmurin combines a good antimicrobial activity with a fairly low hemolytic activity, in contrast to the closely related peptides from T. serrulatus which are either poorly antimicrobial (TsAP-1) or highly hemolytic (TsAP-2) [31] .
There are fewer studies reporting AMPs activity against Candida species, but it is believed that the mechanism of action is similar to that observed in bacteria [40] . The cell wall of yeasts is an anionic surface characterized by its rigidity, being glucans (1,3-␤ and 1,6-␤) the most abundant polysaccharides (around 60%), followed by mannans. Chitin, the less abundant component, corresponds to approximately 1% of all saccharides present in the cell wall [46] . Some scorpions AMPs tested against C. albicans yielded similar results to those we found for Stigmurin, including: TSAP-2 (MIC 10 M) [31] , Meucin-18 (MIC 24.1 M) [29] , and Ctriporin (MIC 20 g/mL) [27] . This data strengthens our results suggesting that Stigmurin could be considered for the treatment of candidiasis.
The results on the cytotoxic activity of Stigmurin indicate a possible differential toxicity toward tumor cells. This is in accordance with observations by other researchers reporting variations in sensitivity of different cell cultures to antitumor AMPs [7, 79] . For instance, peptides present in the venom of the scorpion Tityus discrepans were active against SKBR3 breast cancer cell line, having negligible effect upon monkey kidney cells (MA104) [16] . The exact mechanism of toxicity which differs in different cell types is not yet fully elucidated, but may be related to the negative charge of cancer cell membranes, due to increased expression of molecules with anionic character, such as glycosylated mucins, sialylated gangliosides, and heparin sulfate [30] . Furthermore, it has been reported that cell intrinsic factors influence their sensitivity to toxic substances, including chemical biotransformation and binding forms, characteristics of membrane permeability and surface determinants, intracellular synthesis and mechanisms of adaptation and recovery [9, 64, 84] .
From T. serrulatus, peptide TsAP-2 showed cytotoxicity against five different human cancer cell lines, with IC 50 ranging from 4 to 15 M, whereas TsAP-1 had a less effective antitumoral action [31] . This was in line with their antimicrobial activity; it is thus possible that, like the effect upon microorganisms, Stigmurin's antitumoral potential is more similar to TsAP-2, despite a lower sequence similarity, as discussed above. The IC 50 values obtained in the high M range for Stigmurin upon the two cell lines tested in the present study are not per se indicators of an antitumoral activity; besides potency, other parameters such as maximum effect and the slope of the dose-response curve, should also be taken into account when analyzing putative novel antitumoral drugs [26] . Further studies on a wider panel of tumor cell lineages will be required to suggest a possible anticancer potential for Stigmurin. Nevertheless, this is to our knowledge the first scientific evidence demonstrating the effect of a component of T. stigmurus venom on cell viability of a human cancer cell line. 
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